Experimental Vaccine Reduces Risks Of HIV/AIDS Contagion

Sept. 24, 2009 - Thai health authorities have presented yesterday in Bangkok the results of an HIV/AIDS vaccine studey conducted on more than 16,000 people.

The study conducted in Thailand was sponsored by the US Army Medical Research and the National Institute of Health.

The experimental vaccine (known as RV144) is a combination of two genetically engineered vaccines developed by Sanofi-Aventis SA and VaxGen Inc., whih had failed in previous trials.

The protection offered by this new vaccine is very low, as it only reduces the risk of contagion by 31.2 percent, but the results give some indication that researchers are heading in the right direction.

Read more »
Created by Keiros 14 weeks 3 days ago – Made popular 14 weeks 3 days ago
Category: Health News   Tags:

Washington DC Experiencing HIV/AIDS Epidemic

D.C. Health Department report released Monday says Washington, D.C. is experiencing an HIV/AIDS epidemic.

The Washington, D.C. Health Department released the study that finds that three percent of all residents of the nation's capital are living with HIV or AIDS. The United Nations classifies an HIV infection rate that exceeds one percent as an epidemic.

Earl Fowlkes, Jr. is Executive Director of the District of Columbia Comprehensive AIDS Resource and Education Consortium - a non-profit organization that provides assistance to people with the disease.

"Those of us who do the work in the district know that the rates of infection are very high," said Earl Fowlkes. "We see these cases all the time."

This year's report shows a 22 percent increase in HIV/AIDS cases since 2006. It says that among reported cases, nearly 70 percent are men and 76 percent are African American.

Read more »
Created by Laura 41 weeks 5 days ago – Made popular 41 weeks 5 days ago
Category: Health News   Tags:

A Macaque Model of HIV Infection

“We can quite accurately recapitulate the early stages of infection.” Paul D. Bieniasz

Researchers have taken a major step toward developing a better animal model of human AIDS. Such a model could greatly improve researchers’ ability to evaluate potential strategies for preventing and treating the disease.

Researchers have lacked a reliable animal model in which to study HIV infection, because the virus replicates poorly in most other animals. But now a team assembled by Howard Hughes Medical Institute (HHMI) investigator Paul D. Bieniasz of the Aaron Diamond AIDS Research Center (ADARC) has genetically modified the human virus so that it can infect a species of rhesus monkeys. Viral infection in the monkeys mimics the early stages of HIV infection in humans.

Read more »
Created by Keiros 43 weeks 6 days ago – Made popular 43 weeks 6 days ago
Category: Health News   Tags:


Networked Blogs

Scoops, bookmarking
Join my network